186 related articles for article (PubMed ID: 18202430)
1. Bevacizumab: one treatment for all the seasons?
Gelibter AJ; Di Segni S; Zeuli M; Cognetti F
J Clin Oncol; 2008 Jan; 26(3):511; author reply 511-2. PubMed ID: 18202430
[No Abstract] [Full Text] [Related]
2. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer.
Ferrara N; Hillan KJ; Gerber HP; Novotny W
Nat Rev Drug Discov; 2004 May; 3(5):391-400. PubMed ID: 15136787
[No Abstract] [Full Text] [Related]
3. Bevacizumab beyond progression: does this make sense?
Ellis LM; Haller DG
J Clin Oncol; 2008 Nov; 26(33):5313-5. PubMed ID: 18854567
[No Abstract] [Full Text] [Related]
4. Safety of bevacizumab with fluoropyrimidine-based regimens for first-line treatment of metastatic colorectal cancer.
Tyagi P
Clin Colorectal Cancer; 2006 Sep; 6(3):189-91. PubMed ID: 17026787
[No Abstract] [Full Text] [Related]
5. [New medications; bevacizumab].
Cohen AF; van Bronswijk H
Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2194-5. PubMed ID: 17061430
[TBL] [Abstract][Full Text] [Related]
6. [PZ Innovation Prize for Avastin: Bevacizumab--new therapy option in colon carcinoma].
Krankenpfl J; 2005; 43(7-10):234. PubMed ID: 16515304
[No Abstract] [Full Text] [Related]
7. Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer.
Los M; Roodhart JM; Voest EE
Oncologist; 2007 Apr; 12(4):443-50. PubMed ID: 17470687
[TBL] [Abstract][Full Text] [Related]
8. Introduction. Critical role of anti-angiogenesis and VEGF inhibition in colorectal cancer.
Díaz-Rubio E; Schmoll HJ
Oncology; 2005; 69 Suppl 3():1-3. PubMed ID: 16301829
[No Abstract] [Full Text] [Related]
9. The horizon of antiangiogenic therapy for colorectal cancer.
Olszewski AJ; Grossbard ML; Kozuch PS
Oncology (Williston Park); 2005 Mar; 19(3):297-306; discussion 306, 308, 317-33. PubMed ID: 15828549
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab.
Ellis LM
Nat Rev Drug Discov; 2005 May; Suppl():S8-9. PubMed ID: 15962523
[TBL] [Abstract][Full Text] [Related]
11. Body fatness and bevacizumab-based therapy in metastatic colorectal cancer.
Renehan AG
Gut; 2010 Mar; 59(3):289-90. PubMed ID: 20207633
[No Abstract] [Full Text] [Related]
12. [Bevacizumab. Progress in cancer therapy by antiangiogenesis].
Krämer I; Lipp HP
Med Monatsschr Pharm; 2006 Jul; 29(7):249-54; quiz 255-6. PubMed ID: 16866078
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab in the treatment of metastatic colorectal cancer.
Caprioni F; Fornarini G
Future Oncol; 2007 Apr; 3(2):141-8. PubMed ID: 17381413
[TBL] [Abstract][Full Text] [Related]
14. Regression of a subfoveal choroidal metastasis of colorectal carcinoma after intravitreous bevacizumab treatment.
Kuo IC; Haller JA; Maffrand R; Sambuelli RH; Reviglio VE
Arch Ophthalmol; 2008 Sep; 126(9):1311-3. PubMed ID: 18779499
[No Abstract] [Full Text] [Related]
15. Future directions in vascular endothelial growth factor-targeted therapy for metastatic colorectal cancer.
Grothey A
Semin Oncol; 2006 Oct; 33(5 Suppl 10):S41-9. PubMed ID: 17145524
[TBL] [Abstract][Full Text] [Related]
16. Addition of bevacizumab to chemotherapy for treatment of solid tumors: similar results but different conclusions.
Ocaña A; Amir E; Vera F; Eisenhauer EA; Tannock IF
J Clin Oncol; 2011 Jan; 29(3):254-6. PubMed ID: 21149670
[No Abstract] [Full Text] [Related]
17. Targeted therapy.
Chu E
Clin Colorectal Cancer; 2007 Jan; 6(5):336. PubMed ID: 17311696
[No Abstract] [Full Text] [Related]
18. [Anti-angiogenic treatment and colorectal cancer].
André T; Tournigand C; Abbas F; Louvet C; de Gramont A;
Bull Cancer; 2007 Jul; 94 Spec No():S211-9. PubMed ID: 17846007
[TBL] [Abstract][Full Text] [Related]
19. The role of new agents in the treatment of colorectal cancer.
Ruiz de Erenchun F
Oncology; 2005; 68(2-3):162; author reply 162. PubMed ID: 16097096
[No Abstract] [Full Text] [Related]
20. Current role of bevacizumab in colorectal cancer.
Saltz L
Clin Adv Hematol Oncol; 2009 Jun; 7(6):375-6. PubMed ID: 19606071
[No Abstract] [Full Text] [Related]
[Next] [New Search]
